Specific mutation screening of TP53 gene by low-density DNA microarray

被引:0
|
作者
Rangel-Lopez, Angelica [1 ,2 ,3 ]
Mendez-Tenorio, Alfonso [3 ]
Beattie, Kenneth L. [4 ]
Maldonado, Rogelio [3 ]
Mendoza, Patricia [1 ]
Vazquez, Guelaguetza [1 ]
Perez-Plasencia, Carlos [5 ]
Sanchez, Martha [2 ]
Navarro, Guillermo [6 ]
Salcedo, Mauricio [1 ]
机构
[1] Hosp Oncol, Lab Oncol Genom, Unidad Invest Med Enfermedades Oncol, CMN Siglo XXI IMSS, Mexico City, DF, Mexico
[2] Hosp Especialidades Ctr Med La Raza, CMN Siglo XXI IMSS, Unidad Invest Med Enfermedades Nefrol, Mexico City, DF, Mexico
[3] Escuela Nacl Ciencias Biol, Lab Biotecnol & Bioinformat Genom, Ipn Mexico City, Mexico
[4] Amerigenics Inc, Crossville, TN USA
[5] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol INCAN, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City, DF, Mexico
[6] Univ Nacl Autonoma Mexico, Lab Organomet, Mexico City, DF, Mexico
关键词
oligonucleotide microarray; TP53; gene; point mutations;
D O I
暂无
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
TP53 is the most commonly mutated gene in human cancers. Approximately 90% of mutations in this gene are localized between domains encoding exons 5 to 8. The aim of this investigation was to examine the ability of the low density DNA microarray with the assistance of double tandem hybridization platform to characterize TP53 mutational hotspots in exons 5, 7, and 8 of the TP53. Nineteen capture probes specific to each potential mutation site were designed to hybridize to specific site. Virtual hybridization was used to predict the stability of hybridization of each capture probe with the target. Thirty-three DNA samples from different sources were analyzed for mutants in these exons. A total of 32 codon substitutions were found by DNA sequencing. 24 of them a showed a perfect correlation with the hybridization pattern system and DNA sequencing analysis of the regions scanned. Although in this work we directed our attention to some of the most representative mutations of the TP53 gene, the results suggest that this microarray system proved to be a rapid, reliable, and effective method for screening all the mutations in TP53 gene.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [21] TP53 mutation in colorectal cancer
    Iacopetta, B
    HUMAN MUTATION, 2003, 21 (03) : 271 - 276
  • [22] TP53 mutation in ovarian carcinoma
    Murphy, M
    McManus, DT
    Toner, PG
    Russell, SEH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1281 - 1283
  • [23] TP53 and DNA-repair gene polymorphisms genotyping as a low-cost lung adenocarcinoma screening tool
    Cavic, Milena
    Spasic, Jelena
    Krivokuca, Ana
    Boljevic, Ivana
    Kuburovic, Mira
    Radosavljevic, Davorin
    Jankovic, Radmila
    JOURNAL OF CLINICAL PATHOLOGY, 2019, 72 (01) : 75 - 80
  • [24] Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene
    Bougeard, G
    Brugières, L
    Chompret, A
    Gesta, P
    Charbonnier, F
    Valent, A
    Martin, C
    Raux, G
    Feunteun, J
    Bressac-de Paillerets, B
    Frébourg, T
    ONCOGENE, 2003, 22 (06) : 840 - 846
  • [25] Specific TP53 mutation pattern in radiation-induced sarcomas
    Gonin-Laurent, Nathalie
    Gibaud, Anne
    Huygue, Mathilde
    Lefevre, Sandrine H.
    Le Bras, Morgane
    Chauveinc, Laurent
    Sastre-Garau, Xavier
    Doz, Francois
    Lumbroso, Livia
    Chevillard, Sylvie
    Malfoy, Bernard
    CARCINOGENESIS, 2006, 27 (06) : 1266 - 1272
  • [26] Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
    Zhukova, Nataliya
    Ramaswamy, Vijay
    Remke, Marc
    Pfaff, Elke
    Shih, David J. H.
    Martin, Dianna C.
    Castelo-Branco, Pedro
    Baskin, Berivan
    Ray, Peter N.
    Bouffet, Eric
    von Bueren, Andre O.
    Jones, David T. W.
    Northcott, Paul A.
    Kool, Marcel
    Sturm, Dominik
    Pugh, Trevor J.
    Pomeroy, Scott L.
    Cho, Yoon-Jae
    Pietsch, Torsten
    Gessi, Marco
    Rutkowski, Stefan
    Bognar, Laszlo
    Klekner, Almos
    Cho, Byung-Kyu
    Kim, Seung-Ki
    Wang, Kyu-Chang
    Eberhart, Charles G.
    Fevre-Montange, Michelle
    Fouladi, Maryam
    French, Pim J.
    Kros, Max
    Grajkowska, Wieslawa A.
    Gupta, Nalin
    Weiss, William A.
    Hauser, Peter
    Jabado, Nada
    Jouvet, Anne
    Jung, Shin
    Kumabe, Toshihiro
    Lach, Boleslaw
    Leonard, Jeffrey R.
    Rubin, Joshua B.
    Liau, Linda M.
    Massimi, Luca
    Pollack, Ian F.
    Ra, Young Shin
    Van Meir, Erwin G.
    Zitterbart, Karel
    Schueller, Ulrich
    Hill, Rebecca M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) : 2927 - +
  • [27] Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumors
    Favis, R
    Huang, JM
    Gerry, NR
    Culliford, A
    Paty, P
    Soussi, T
    Barany, F
    HUMAN MUTATION, 2004, 24 (01) : 63 - 75
  • [28] DNA-based biosensor platforms for the detection of TP53 mutation
    Altintas, Z.
    Tothill, I. E.
    SENSORS AND ACTUATORS B-CHEMICAL, 2012, 169 : 188 - 194
  • [29] DNA Damage Is a Potential Marker for TP53 Mutation in Colorectal Carcinogenesis
    Scalise J.R.
    Poças R.C.G.
    Caneloi T.P.
    Lopes C.O.
    Kanno D.T.
    Marques M.G.
    Valdivia J.C.M.
    Maximo F.R.
    Pereira J.A.
    Ribeiro M.L.
    Priolli D.G.
    Journal of Gastrointestinal Cancer, 2016, 47 (4) : 409 - 416
  • [30] Endogenous DNA damage and TP53 mutation profiles in human cancers
    Hainaut, P
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 153 - 154